Abstract

Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients

Author(s): Mixon Bill, Ille Gary

Issue: Jul/Aug 2009 - Homone Replacement Therapy

Page(s): 290-294

Download in electronic PDF format for $75
  • Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Page 1
  • Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Page 2
  • Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Page 3
  • Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Page 4
  • Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Page 5

Abstract

Preventing and minimizing exposure to nonmicrobiologic airborne contaminants in a compounding pharmacy protects the health of pharmacy staff and clients. The inhalation of hazardous substances has been linked to development of diseases and disorders that range from cancer to infertility. Although a workplace environmental exposure level has been established for some antibiotics, at the time of this writing there were no exposure limits recommended by the National Institute for Occupational Safety and Health or permitted by the Occupational Safety and Health Administration for hazardous drugs or pharmaceutical compounds, nor were threshold limit values for those substances specified by the American Conference of Governmental Industrial Hygienists. For that reason, an evaluation of environmental air quality performed by an industial hygienist can yield valuable information that will reassure staff or provide the basis for remedial action. This report describes the assessment by an industrial hygienist of airbor

Related Keywords

  • airborne contaminants
  • workplace safety
  • worker health
  • occupational exposure
  • standards
  • industrial hygiene
  • hormones
  • sex steroids
  • air quality monitoring
  • pharmacy staff
  • employees

Related Categories

  • BUSINESS
  • ENVIRONMENTAL
  • STERILE PREPARATIONS
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2009
Pg. 290-294
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Author(s): Mixon Bill, Ille Gary
Jul/Aug 2020
Pg. 270-276
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2020
Pg. 451-458
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
May/Jun 2013
Pg. 182-190
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Author(s): Mixon Bill, Nain John
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Nov/Dec 2006
Pg. 446-448
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2013
Pg. 485-489
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Author(s): Prince Bryan, Lundeval Jeremy
Sep/Oct 2021
Pg. 356
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 257-263
Trace Level Analysis of Airborne Hormone Particulates
Author(s): Trimble John O, Hampton Shanna
Nov/Dec 2020
Pg. 519-527
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Author(s): Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott
Jul/Aug 2020
Pg. 287-295
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
Author(s): McElhiney Linda F
May/Jun 2019
Pg. 182-186
How to Develop and Maintain a Hazardous Drug List
Author(s): Dillon L Rad
Jul/Aug 2019
Pg. 271-278
Contamination Control in Compounding Areas
Author(s): Mulder Kyle, Gonzales Ben A
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jul/Aug 2014
Pg. 270-276
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Author(s): Johnson Kain, Sully Andrew, Anthenat Bruce
Sep/Oct 2018
Pg. 369-384
Certification of Powder-containment Hoods for Nonsterile Compounding
Author(s): Mulder Kyle, Dozzi Raphael
Nov/Dec 2019
Pg. 511-518
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Author(s): Hutson Chad, Day A J
Sep/Oct 2022
Pg. 432-435
Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions
Author(s): Marianni Bruna, Polonini Hudson
Nov/Dec 2022
Pg. 497-504
Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Author(s): Summers Amy